Alexion Pharmaceuticals Inc (ALXN) Q4 2019 Earnings Conference Call January 30, 2020 7:30 AM ET
Company Participants
Morgan Sanford - Director of Investor Relations
Ludwig Hantson - Chief Executive Officer
Aradhana Sarin - Chief Financial Officer
John Orloff - Global Head of R&D
Brian Goff - Chief Commercial and Global Operations Officer
Conference Call Participants
Cory Kasimov - JP Morgan
Geoff Meacham - Bank of America
Geoffrey Porges - SVB Leerink
Chris Raymond - Piper Sandler
Josh Schimmer - Evercore
Kostas Biliouris - Morgan Stanley
Robyn Karnauskas - SunTrust Robinson
Mohit Bansal - Citigroup
Kennen MacKay - RBC Capital Markets
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Alexion Pharmaceuticals Fourth Quarter and Full Year 2019 Results Conference Call. At this time, all participant lines are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. Please be advised, that today's conference may be recorded.
I would now like to hand the conference over to Morgan Sanford, Director, Investor Relations. Please go ahead ma'am.
Morgan Sanford
Thank you, operator. Good morning. Thank you for joining us on today's call to discuss Alexion's performance for the fourth quarter and full year 2019. Today's call will be led by Ludwig Hantson, our CEO. Ludwig will be joined by Aradhana Sarin, our Chief Financial Officer; John Orloff, our Global Head of R&D; and Brian Goff, our Chief Commercial and Global Operations Officer. You can access the webcast slides that will be presented on this call, by going to the Events section of our Investor Relations page on our website.
Before we begin, I would like to point out that we will be making forward-looking statements, and these statements involve certain risks and uncertainties that could cause our actual results to differ materially. Please take a look at the
- Read more current ALXN analysis and news
- View all earnings call transcripts